soul trial oral semaglutide cardiovascular outcomes 2024 results nejm of and tirzepatide for patients with type 2 diabetes in clinical practice Oral Semaglutide and Cardiovascular Outcomes
Description
The body is shedding weight quickly, and without adequate nutrition, you risk excessive lean mass loss, micronutrient deficiencies, fatigue, and hair thinning that sometimes accompanies GLP-1 medications
The liveralpha-cell axis in health and in disease
Combining tirzepatide with hormone therapy adds roughly 35% more weight loss per Mayo Clinic ENDO 2025, especially relevant for hormonal belly fat redistribution
Your healthcare provider can provide dietary guidelines to support your weight loss goals
While Semaglutide can promote overall weight loss, specifically targeting belly fat remains elusive
